{"id":"F2007B01105","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 13 of 1999)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-13-of-1999","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":67868,"registerId":"commonwealth-F2007B01105-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 13 of 1999)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85 (2AA)\n\nNo. PB 13 of 1999\n\nI, BRETT ANTHONY LENNON, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Aged Care and Delegate of the Minister for Health and Aged Care, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:\n\n1.  This Declaration shall come into operation on 1 November 1999.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nClindamycin Palmitate Hydrochloride with Purified Water B.P.\n\nDexamethasone Sodium Phosphate\n\nDihydrotachysterol\n\nProcyclidine Hydrochloride\n\nTrimipramine Maleate\n\n\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\\_\n\nDated this 27th day of September 1999.\n\nBRETT ANTHONY LENNON\n\nAssistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health and Aged Care\n\nDelegate of the Minister for Health and Aged Care","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":2271},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"The declaration is limited to its explicit purpose of removing five specified drugs from the Pharmaceutical Benefits Scheme. There is no evidence of scope expansion beyond the original legislative intent of managing PBS listings."},"complexity_factors":["Very short instrument (single page)","Only 5 items listed in the Schedule","No conditional provisions or exceptions","Simple declarative structure with no nested logic","Minimal cross-referencing (only to parent Act section)"],"plain_english_summary":"This instrument removes subsidy for five prescription medicines from Australia’s Pharmaceutical Benefits Scheme — Clindamycin Palmitate HCl, Dexamethasone Sodium Phosphate, Dihydrotachysterol, Procyclidine HCl and Trimipramine Maleate — so patients must generally pay the full price unless they qualify for hardship provisions or receive a subsidised alternative. The delegate acted on PBAC advice; the change took effect 1 November 1999."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-13-of-1999","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-13-of-1999/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-13-of-1999/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-13-of-1999/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-13-of-1999/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-13-of-1999/documents"}}